Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 20;133(8):968-974.
doi: 10.1097/CM9.0000000000000748.

Advances in the role of helper T cells in autoimmune diseases

Affiliations
Review

Advances in the role of helper T cells in autoimmune diseases

Xiao-Mei Zhang et al. Chin Med J (Engl). .

Abstract

Autoimmune diseases are primary immune diseases in which autoreactive antibodies or sensitized lymphocytes destroy and damage tissue and cellular components, resulting in tissue damage and organ dysfunction. Helper T cells may be involved in the pathogenesis of autoimmune diseases under certain conditions. This review summarizes recent research on the role of helper T cells in autoimmune diseases from two aspects, helper T cell-mediated production of autoantibodies by B cells and helper T cell-induced activation of abnormal lymphocytes, and provides ideas for the treatment of autoimmune diseases. The abnormal expression of helper T cells promotes the differentiation of B cells that produce autoantibodies, which leads to the development of different diseases. Among them, abnormal expression of Th2 cells and T follicular helper cells is more likely to cause antibody-mediated autoimmune diseases. In addition, abnormal activation of helper T cells also mediates autoimmune diseases through the production of abnormal cytokines and chemokines. Helper T cells play an essential role in the pathogenesis of autoimmune diseases, and a full understanding of their role in autoimmune diseases is helpful for providing ideas for the treatment of autoimmune diseases.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Fagiolo E. Immunological tolerance loss vs. erythrocyte self antigens and cytokine network disregulation in autoimmune hemolytic anaemia. Autoimm Rev 2004; 3:53–59. doi: 10.1016/S1568-9972(03)00085-5. - PubMed
    1. Barcellini W, Clerici G, Montesano R, Taioli E, Morelati F, Rebulla P, et al. In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytoline stimulation. Br J Haematol 2000; 111:452–460. doi: 10.1046/j.1365-2141.2000.02380.x. - PubMed
    1. Xu L, Zhang T, Liu Z, Li Q, Xu Z, Ren T, et al. Critical role of Th17 cells in development of autoimmune hemolytic anemia. Exp. Hematol 2012; 40:994–1004. doi: 10.1016/j.exphem.2012.08.008. - PubMed
    1. Ahmad E, Elgohary T, Ibrahim H. Naturally occurring regulatory T Cells and interleukins 10 and 12 in the pathogenesis of idiopathic warm autoimmune hemolytic anemia. J Investig Allergol Clin Immunol 2011; 21:297–304. - PubMed
    1. Mqadmi A, Zheng X, Yazdanbakhsh K. CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia. Blood 2005; 105:3746–3748. doi: 10.1182/blood-2004-12-4692. - PMC - PubMed

MeSH terms